Meet D2's Integrated PA Appeals Processing with a 94% Success Rate

The burden of managing and completing appeals for prior authorizations is a significant drain on healthcare providers, consuming valuable time and resources that could be dedicated to patient care. The inherent difficulty can lead to therapy abandonment or alternatives to the prescriber’s preferred medication.

D2 has been partnering with healthcare providers in support of their prior authorization workflows since 2021; consistently optimizing our PA management platform, UltraTouch® Verify, to better serve the thousands of patients in our client’s care. In this vein, we are excited to announce Verify’s new appeals management integration designed to streamline appeal processes and significantly reduce appeals burden on staff.

AMA's 2024 Prior Authorization Physician Survey reported that 67% of physicians do not believe their appeals will be successful based on past experiences. In June 2025 alone, UltraTouch® Verify achieved a 94.4% approval rate on appealed, previously denied, Prior Authorizations.

"Appeals should not be inherently difficult. Physicians shouldn't have to choose between patient care and arduous PA processing. UltraTouch Verify really is a gold-standard PA platform... and it just got better."

- Jim Maguire, CIO/CTO at D2 Solutions

Verify's updated feature set includes:

• Integrated appeals workflow – all in the UltraTouch Platform.
  Appeals are handled completely within the UltraTouch platform minimizing turnaround time and eliminating the need for phone calls. This is critically valuable as certain therapies enforce a 12 hour or less time limit for appeal responses.
  
• Integrated Step Therapy Exception Forms available in 37 states.
• AI analysis of journal articles. 
  Automated search to find relevant Payer and therapy information to help overturn denials.
  

Interested in discussing how the UltraTouch Verify platform could support your team's PA processing? Reach out. We look forward to connecting with you!